Neureka for Epilepsy

Early Stage

Epilepsy care reimagined

Overview

Raised to Date: Raised: $75,071

Total Commitments ($USD)

Platform

Republic

Start Date

02/14/2023

Close Date

04/15/2023

Min. Goal

$25,000

Max. Goal

$1,235,000

Min. Investment

$150

Security Type

SAFE

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$25,000,000

Discount

20%

Rolling Commitments ($USD)

Status

Active

Reporting Date

03/27/2023

Days Remaining

19

% of Min. Goal

300%

% of Max. Goal

6%

Likelihood of Max
unlikely
Avg. Daily Raise

$1,831

# of Investors

77

Momentum
cold.svg
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2018

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B/B2C

Margin

Low

Capital Intensity

Low

Location

Alameda, California

Business Type

Growth

Neureka for Epilepsy, with a valuation of $25 million, is raising funds on Republic. The company provides AI-powered wearable devices for on-demand epilepsy care. The wearable device captures health data, connects patients with their care teams, and empowers doctors with data to make better treatment decisions. Neureka for Epilepsy is backed by ten years of R&D and is accelerating its epilepsy center partnerships and B2C market traction. Ray Iskander and Parisa Sabetian founded Neureka for Epilepsy in February 2018. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $1.24 million. The campaign proceeds will be used for new product marketing, research and development, new hires, and general working capital.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-1,393,497

$-962,316

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$281,299

$64,459

Accounts Receivable

$0

$0

Total Assets

$286,340

$71,179

Short-Term Debt

$50,065

$34,704

Long-Term Debt

$20,171

$42,167

Total Liabilities

$70,236

$76,871

Financials as of: 02/14/2023
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Analyst Report Analyst Report Methodology Article

Pending Review
Are you the founder of Neureka for Epilepsy? Create your account today to claim this raise page.

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Neureka for Epilepsy on Republic 2023
Platform: Republic
Security Type: SAFE
Valuation: $25,000,000

Follow company

Follow Neureka for Epilepsy on Republic 2023
View on Republic